WhiteLab Genomics

Unleashing the potential of DNA and RNA based therapies using AI

Winter 2022

Active

artificial-intelligence

gene-therapy

cell-therapy

genomics

https://whitelabgx.com

Unleashing the potential of DNA and RNA based therapies using AI

We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.

Active Founders

David Delbourgo

David Delbourgo, Founder

23 y of experience in healthcare innovation with multiple executive roles in Business Development, Marketing and Commercial Operations. Former GE Healthcare. MBA Chicago Booth, Biomedical Engineer MS University of Compiègne, France.

Julien Cottineau

Julien Cottineau, Founder

Senior application scientist at Genomic Vision, leading provider of genetic devices and platform Research fellow at Rockefeller Univ & Necker Hospital on human complex immune deficiencies in J-L Casanova’s lab PhD in genetics, molecular biology & immunology at Université Pierre & Marie CurieWith Honors